Abiraterone Tablet
Product Images NDC 82009-139

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 82009-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abiraterone-250mg-120s-container-label (Abiraterone 250mg 120s Container Label)

Abiraterone Acetate Tablets, USP 250 mg film-coated tablets label. Contains 120 tablets. Warning advises pregnant women not to handle tablets without gloves. Manufactured by MSN Laboratories Private Limited, India, for Quallent Pharmaceuticals Health LLC. Storage instructions and swallowing guidance are included, with barcode and NDC 82009-139-12 visible.*

FDA Label Image

Figure-01 (Abiraterone Figure 01)

A Kaplan-Meier survival curve comparing percent survival over time (months) to death between Abiraterone and placebo groups. The graph shows two survival curves with numerical data for remaining subjects at specific time points, indicating survival trends for Abiraterone versus placebo.*

FDA Label Image

Figure-02 (Abiraterone Figure 02)

A Kaplan-Meier survival curve showing the percentage of subjects without death over months from randomization for Abiraterone and placebo groups. The vertical axis represents percent of subjects without death, and the horizontal axis shows time in months from 0 to 60. The graph includes a legend and the number of subjects at risk for each group at various time points below the axis.*

FDA Label Image

Figure-03 (Abiraterone Figure 03)

A Kaplan-Meier survival curve comparing Abiraterone versus placebo over 18 months, showing the percentage of subjects without radiographic progression or death on the y-axis and months from randomization on the x-axis. The solid line represents Abiraterone, and the dashed line represents placebo, with corresponding subject numbers at various time points displayed below the graph.*

FDA Label Image

Abiraterone-figure-04 (Abiraterone Figure 04)

A survival curve chart showing the percentage of subjects without death over months from randomization, comparing Abiraterone tablets (represented by circles) versus placebo (represented by triangles). The x-axis indicates months from randomization up to 72 months, and the y-axis shows the percentage survival from 0 to 100%. The graph includes the number of subjects at risk for each group over time at the bottom.*

FDA Label Image

Abiraterone-structure (Abiraterone Structure)

Chemical structure of abiraterone acetate, illustrating the molecular arrangement of its steroidal core and attached functional groups, including an acetoxy group and a pyridine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.